Associated Papers
A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks.
Batu ED et al.
Rheumatology (oxford, England), 2025
Osteopontin as an early predictor of atherosclerosis in attack-free Familial Mediterranean fever patients.
Baspinar O et al.
Medicine, 2023
Importance of hematological markers in familial Mediterranean fever in terms of disease severity and amyloidosis.
Tezcan ME et al.
Rheumatology International, 2023
Similarities between pediatric FMF patients with sacroiliitis and pediatric juvenile spondyloarthropathy patients with sacroiliitis: a preliminary study.
Özdel S et al.
Acta Clinica Belgica, 2021
A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S et al.
The Journal of Rheumatology, 2020
Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease.
Topaloglu R et al.
International Journal of Rheumatic Diseases, 2018
Increased psoriasis frequency in patients with familial Mediterranean fever.
Erden A et al.
Upsala Journal of Medical Sciences, 2018
Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
Sönmez HE et al.
Clinical Rheumatology, 2017
Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas.
Batu ED et al.
Arthritis Care & Research, 2016
Clinical Profile of Familial Mediterranean Fever in a Paediatric Population in Eastern Turkey.
Kosan C et al.
The West Indian Medical Journal, 2015
Select a paper to view details